Antibodies against APRIL as biomarkers for early prognosis of lymphoma pa- tients

Details for Australian Patent Application No. 2006298794 (hide)

Owner Enzo Life Sciences, Inc. University of Geneva

Inventors French, Lars; Murone, Maximilien; Huard, Bertrand; Donze, Olivier

Agent Watermark

Pub. Number AU-B-2006298794

PCT Pub. Number WO2007/039489

Priority 05020881.8 26.09.05 EP

Filing date 22 September 2006

Wipo publication date 12 April 2007

Acceptance publication date 10 May 2012

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C12N 5/16 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039489 Priority application(s): WO2007/039489

16 February 2012 Assignment before Grant

  Apotech Corporation; University of Geneva The application has been assigned to Enzo Life Sciences, Inc.; University of Geneva Assignments before Grant, Section 113

10 May 2012 Application Accepted

  Published as AU-B-2006298794

6 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006298800-Articulation joint which can be locked by means of elastic deformation and knee prosthesis using same

2006298787-Thiophene derivatives for the treatment of diabetes